Q: Apparently RHT held a conference call this morning. The stock is up over 25% as well. Do you know if something material was announced? I was planning to sell, but wasn't sure if some new news came out.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: With all the talk of an admittedly bad mistake (at best) by management, what has happened to the technology? Didn't you believe in iUgo and the accompanying smart phone app and the jump this company supposedly had in producing a superior remote monitoring product for chronic care patients? But they bruise their heals because they didn't understand CMS billing well enough and, oh well, so much for that technology? Is it great technology or not? Will it save government health care money or not? If it will, then surely CMS will come around and recognize this and eventually reimburse for the service, no? This all just seems odd that one day you're touting this company as having the one of the best technology stories in the health technology space, and the next they are a dog because they made a mistake. Is there no room for growing pains for a start up?
Q: I was wondering if you people monitored the conference call for reliq that was on this morning at 9 am . The stock seams to be up the last 2 days . What info was released that may be causing the rise, or, do you not bother covering the stock once you give a negative opinion on it. Thank you.
Q: Would you be surprised if this company got their act together or is the latest news destined to doom the company?
The value left is so small that I don’t think selling would really improve the overall return.
Is is more likely to go to zero than to regain its form?
Thanks.
The value left is so small that I don’t think selling would really improve the overall return.
Is is more likely to go to zero than to regain its form?
Thanks.
Q: I’m sure that you’re as upset as the members about RHT. I’ve made money with your service and am very happy overall especially because in this case I stuck with your weighting recommendation.
This is a question regarding why you put RHT in the balanced portfolio? Hindsight of course is 20/20 but as a growth play, it probably should have been in the growth portfolio. If it were, many the members might be a little harder on themselves rather than you folks.
This is a question regarding why you put RHT in the balanced portfolio? Hindsight of course is 20/20 but as a growth play, it probably should have been in the growth portfolio. If it were, many the members might be a little harder on themselves rather than you folks.
Q: In my TFSA my strategy was to anchor this portfolio with blue chip positions which had worked to achieve my initial goal of making a steady foothold in the market. I then decided to add a few growth positions to see if I could improve the return on the portfolio. The only one in positive territory is PHO up 10%, do you think as a strategy this has the potential to work or not,also do you feel that ECN & TGSI have the potential to thrive in the future I'm down 10% on ECN & 36% on TGSI. I do not intend to draw down from this TFSA so I can wait. I know the answer on RHT
Q: As a new DIY investor following the Q&A on RHT about to adopt a position, today's news is intriguing. An experienced investor friend tells me that penny stocks on the Vancouver exchange should be avoided due to increased likelihood of fraud and "pump & dump" schemes. It seems the CEO and one of her execs have a history of starting tech companies with government subsidies, taking them public, then bailing. How can we avoid these "games"? I'm assuming your own research process aims to identify frauds in the making. Thanks
Q: On the financials that came out May 30th 2018 (9 months ended Mar 31 2018) it indicates that RHT billed $2.27 MM in revenue.
It also indicates an increase of total receivables of $1.95 MM, from $34K to $1.99 MM total.
At the time of these financials (May 30th), could this have been construed as a bearish signal, given that 86% of the total recorded revenue ($1.95 MM/$2.27 MM) was as of yet uncollected ?
It also indicates an increase of total receivables of $1.95 MM, from $34K to $1.99 MM total.
At the time of these financials (May 30th), could this have been construed as a bearish signal, given that 86% of the total recorded revenue ($1.95 MM/$2.27 MM) was as of yet uncollected ?
Q: As a member of 5i since 2013 I have used your wise logic as one of the tools to help me position my portfolio. I have had some Major wins with your help, but this has been a gut wrenching experience and I have learned the hard way that keeping a reasonable weighting of any one stock is of paramount importance. I let RHT get too large a weighting and believed in their product as a way to help people. It concerns me that you used the word 'fraud' in one of your previous replies.
I have now reduced most of my position to a very small weighting and am reviewing selling it all.
I have a position in COV that is a full position. It is a bit weak of late but I think that is due to the Saudi Arabian rhetoric and is a temporary blip.
Would you consider VMD to be a good replacement for RHT.
Thanks for all your solid advise in these turbulent times.
Peter
I have now reduced most of my position to a very small weighting and am reviewing selling it all.
I have a position in COV that is a full position. It is a bit weak of late but I think that is due to the Saudi Arabian rhetoric and is a temporary blip.
Would you consider VMD to be a good replacement for RHT.
Thanks for all your solid advise in these turbulent times.
Peter
Q: With this latest revenue fiasco at RHT I am swearing off Canadian healthcare stocks for good. I have been a 5i member since day one, greatly value your service and am not trying to lay any blame here. I lost 80% with Patient Home Monitoring and 97% with Concordia before getting out of these, and am now down 85% with RHT. I agree no one is clairvoyant, but this seems to be a recurring theme in Canadian healthcare. Any thoughts on how we can spot and stay away from names like these in the future?
Q: Is it time to sell and move on?
Q: It doesn't always work and some picks are disappointing but thanks for preaching diversification and reasonable stock weightings. As a % of my portfolio the loss will easily be covered. What I am not sure is how to divest my position for maximum return. Should I just bail ,let the dust settle or is the drop oversold and should I hold. Thanks John
Q: The other day a question was asked about this Company and earnings reporting. You had suggested that you would contact the Company for confirmation. Any word?
As a follow up, your best guess as to the run on the stock would be appreciated. I note that there doesn’t appear to be any insider buying, is that problematic if insiders don’t believe in their own stock at such a discount to its yearly high? Or are they blacked out from purchasing stock?
All the best!
KC
As a follow up, your best guess as to the run on the stock would be appreciated. I note that there doesn’t appear to be any insider buying, is that problematic if insiders don’t believe in their own stock at such a discount to its yearly high? Or are they blacked out from purchasing stock?
All the best!
KC
Q: You keep saying that nothing has changed. A stock doesn't drop 70% when nothing changes. Something is very fishy here and it stinks. It looks more and more like PHM and CRX. While it may be that there are two sides of each trades, only one is right (and makes money).
Q: Can we get your view.on RHT with this mornings development
Q: How come RHT has not released any quarterly and annual income statement for June 30,2018? Thanks
Q: For lack of better words, many stocks are presently on sale OR are atleast much lower than we paid for them, sometimes by a huge (very huge) margin. Assuming these opportunities are real, it would be an ideal time to add a little.
My understanding of your assessment is that you have high hopes for this company, believe that nothing has changed other than unpredictable market forces.
The stock has really dropped, which does not imply a bargain if it is still overpriced; however, my understanding is that we liked the stock at $2.00 and nothing has changed, so I must believe that this a great buying opportunity as long as we continue to properly diversify and understand that this may take 5-10 years. Your thoughts on this as a buying opportunity? Any new input from their mgmt? Any concerns with cash burnout over time? Other than wishing there were more sales contracts (which is definitely key), any other issues?
I ask these questions because I feel that we like to jump on the bandwagon when it is moving uphill with great momentum but want to ignore it when it is unwanted, even though it is the same bandwagon (i.e. same fundamentals). As a general comment are we not following a herd mentality (which is not wrong in itself on many occassions)? Should we not be greedy (at times) when others are fearful? I know this these are hard, fundamental questions about investing but your thoughts are appreciated OR maybe this could be the theme of a future blog... (I think that these are opportune times to pick up shares in companies we like even though their momentum is negative, even though we are buying the dips, even though we are possibly doubling down...)
As an aside, this was recently published. I just saw it this morning.
https://patient-monitoring.healthcaretechoutlook.com/vendors/top-patient-monitoring-solution-providers-2018.html
Thanks again!
My understanding of your assessment is that you have high hopes for this company, believe that nothing has changed other than unpredictable market forces.
The stock has really dropped, which does not imply a bargain if it is still overpriced; however, my understanding is that we liked the stock at $2.00 and nothing has changed, so I must believe that this a great buying opportunity as long as we continue to properly diversify and understand that this may take 5-10 years. Your thoughts on this as a buying opportunity? Any new input from their mgmt? Any concerns with cash burnout over time? Other than wishing there were more sales contracts (which is definitely key), any other issues?
I ask these questions because I feel that we like to jump on the bandwagon when it is moving uphill with great momentum but want to ignore it when it is unwanted, even though it is the same bandwagon (i.e. same fundamentals). As a general comment are we not following a herd mentality (which is not wrong in itself on many occassions)? Should we not be greedy (at times) when others are fearful? I know this these are hard, fundamental questions about investing but your thoughts are appreciated OR maybe this could be the theme of a future blog... (I think that these are opportune times to pick up shares in companies we like even though their momentum is negative, even though we are buying the dips, even though we are possibly doubling down...)
As an aside, this was recently published. I just saw it this morning.
https://patient-monitoring.healthcaretechoutlook.com/vendors/top-patient-monitoring-solution-providers-2018.html
Thanks again!
Q: Do you still consider this stock a buy? Would it be better to wait until after tax loss selling? Do you still believe in it long term?
Q: Earlier you said RHT reports earnings today, I cannot find their earnings date anywhere nor any releases indicating it will be today, can you confirm that it is today?
Q: Announced that it was selected by Premier Health Group as exclusive technology partner today & RHT dropped 10%.It has steadily declined from its $2.50 high in March.What is happening?I have lost 59%.Your advice please.Thanks for u usual great services & views